Starbucks says employees must get vaccine or test weekly


This is a Starbucks sign in a coffee shop in Pittsburgh, Nov. 13, 2021. Starbucks says its U.S. workers must be fully vaccinated by Feb. 9 or face a weekly COVID testing requirement. The Seattle-based coffee giant said Monday, Jan. 3, 2021 it was acting in response to the Occupational Safety and Health Administration, which issued a vaccine-or-test requirement for companies with more than 100 employees in November. (AP Photo/Gene J. Puskar)

Starbucks says its U.S. workers must be fully vaccinated by Feb. 9 or face a weekly COVID testing requirement.

The Seattle-based coffee giant said Monday it was acting in response to the Occupational Safety and Health Administration, which issued a vaccine-or-test requirement for companies with more than 100 employees in November.

The requirement, which has faced numerous court challenges, was upheld last month by a three-judge panel with the U.S. Court of Appeals. The Supreme Court is scheduled to consider the requirement on Friday.

Starbucks is requiring its 228,000 U.S. employees to disclose their vaccination status by Jan. 10.

“I recognize that partners have a wide spectrum of views on vaccinations, much like the rest of the country,” Starbucks Chief Operating Officer John Culver said in a letter sent to employees in late December. “My responsibility, and that of every leader, is to do whatever we can to help keep you safe and create the safest work environment possible.”

Starbucks said full vaccination means two shots of either the Pfizer or Moderna vaccine or one shot of the Johnson & Johnson vaccine.

If a Starbucks employee chooses to test weekly instead, they must pay the cost of testing themselves and get tested a pharmacy, clinic or other testing site where someone is observing the test. Religious or medical accommodations will be considered, but to work in a store, employees must test weekly, the company said.

Employees who test positive will be able to use paid time to self-isolate. Starbucks said it is currently offering employees two instances of paid isolation time, both up to five days each.

Should you invest $1,000 in Johnson & Johnson right now?

Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)
4.9067 of 5 stars
$148.07-1.0%3.21%9.23Hold$175.86
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: